KR100273742B1 - Lactococcus lactis microorganism producing natural antibacterial substances (KFCC 11047) - Google Patents

Lactococcus lactis microorganism producing natural antibacterial substances (KFCC 11047) Download PDF

Info

Publication number
KR100273742B1
KR100273742B1 KR1019980040669A KR19980040669A KR100273742B1 KR 100273742 B1 KR100273742 B1 KR 100273742B1 KR 1019980040669 A KR1019980040669 A KR 1019980040669A KR 19980040669 A KR19980040669 A KR 19980040669A KR 100273742 B1 KR100273742 B1 KR 100273742B1
Authority
KR
South Korea
Prior art keywords
bacteriocin
lactic acid
lactococcus lactis
acid bacteria
activity
Prior art date
Application number
KR1019980040669A
Other languages
Korean (ko)
Other versions
KR20000021520A (en
Inventor
최학종
최찬익
이한승
김태석
여익현
안철
백현동
현형환
변유량
Original Assignee
남승우
주식회사풀무원
변유량
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 남승우, 주식회사풀무원, 변유량 filed Critical 남승우
Priority to KR1019980040669A priority Critical patent/KR100273742B1/en
Publication of KR20000021520A publication Critical patent/KR20000021520A/en
Application granted granted Critical
Publication of KR100273742B1 publication Critical patent/KR100273742B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

(1) 청구범위에 기재된 발명이 속하는 기술분야(1) The technical field to which the invention described in the claims belongs

천연항균물질을 생산하는 락토코커스락티스 미생물에 관한 것이다.It relates to a lactococcus lactis microorganism producing a natural antibacterial substance.

(2) 발명이 해결하려고 하는 기술적 과제(2) The technical problem to be solved by the invention

본 발명은 대부분의 젖산균과 병원성 미생물에 대해 항균활성을 가지는 분자량분자량 5.0-5.5 KDa의 순수한 박테리오신을 생산하는 락토코커스 락티스 서브스피시즈 락티스 A164(KFCC-11047)미생물을 제공하는데 그 목적이 있다.It is an object of the present invention to provide a Lactococcus lactis subsp. Lactis A164 (KFCC-11047) microorganism that produces a pure bacteriosin of molecular weight molecular weight 5.0-5.5 KDa having antimicrobial activity against most lactic acid bacteria and pathogenic microorganisms.

(3) 발명의 해결방법의 요지(3) Summary of the solution method of the invention

본 발명은 항균 활성이 넓고 강한 박테리오신을 생산하는 젖산균인 락토코커스 락티스 A164로부터 박테리오신을 분리, 정제하여 특성을 조사하고 본 박테리오신이 대부분의 젖산균과 여러 종류의 병원성 세균에 대하여 저해효과가 있으며, 열과 pH에 안정하며, 분자량 5.0-5.5 KDa의 박테리오신을 생산하는 것을 특징으로 한다.The present invention is to isolate and purify the bacteriocin from lactic acid bacteria lactococcus lactis A164, which produces a broad bacteriocin, which has a high antibacterial activity, and the bacteriocin has an inhibitory effect on most lactic acid bacteria and various pathogenic bacteria. It is stable to pH and is characterized by producing a bacteriocin having a molecular weight of 5.0-5.5 KDa.

(4) 발명의 중요한 용어(4) important terms of the invention

본 발명에 의한 균주는 대부분의 젖산균과 병원성 미생물에 대하여 저해효과를 가지며, 산과 열에 안정하는 박테리오신의 특징을 지니고 있어서 식품첨가물이나 약품의 원료로 사용되어 보존성 연장 및 항균효과를 나타내므로 제품 품질 및 가격 경쟁력에서 비교우위를 점할 수 있다.The strain according to the present invention has an inhibitory effect on most lactic acid bacteria and pathogenic microorganisms, and has a characteristic of bacteriocin that is stable to acid and heat, so it is used as a food additive or a raw material of pharmaceuticals to show extended shelf life and an antimicrobial effect. Competitive advantage can be competitive.

Description

천연 항균물질을 생산하는 락토코커스 락티스 미생물(KFCC 11047)Lactococcus lactis microorganism producing natural antibacterial substances (KFCC 11047)

제1도는 여러 젖산균들의 전체 세포 단백질 형식을 에스디에스 폴리아크릴아마이드 겔 전기영동으로 나타내는 사진이다.FIG. 1 is a photograph showing the whole cell protein format of several lactic acid bacteria by SD polyacrylamide gel electrophoresis.

1. 표준 분자량 단백질1. Standard Molecular Weight Protein

2. 락토바실러스 브레비스 ATCC 13648의 전체 세포 단백질2. Whole Cell Protein of Lactobacillus Brevis ATCC 13648

3. 락토바실러스 브레비스 ATCC 14869의 전체 세포 단백질3. Whole Cell Protein of Lactobacillus Brevis ATCC 14869

4. 락토코커스 락티스 서브스피시즈 락티스 ATCC 11454의 전체 세포 단백질4. Whole Cell Proteins of Lactococcus Lactis Subspices Lactis ATCC 11454

5. LAB-A164의 전체 세포 단백질5. Whole Cell Protein of LAB-A164

6. 엔테로코커스 피칼리스 ATCC 19433의 전체 세포 단백질6. Whole Cell Protein of Enterococcus picalis ATCC 19433

제2도는 본 균주 LAB-A164를 M17 액체배지에서 배양하면서 시간별로 균체증식과 박테리오신활성을 나타내는 그림이다.2 is a diagram showing the cell growth and bacteriocin activity by time while culturing the strain LAB-A164 in M17 liquid medium.

제3도는 본 균주의 부분 정제액에 의하여 락토바실러스 사께의 저해 현상을 페트리 접시에서 나타낸 사진이다.3 is a photograph showing the inhibition of Lactobacillus to the petri dish by partial purification of the strain.

A. 무처리한 부분 정제액A. Untreated Partial Purifying Liquid

B. α -chymotrypsin을 처리한 부분 정제액B. Partial Purified Solution Treated with α-chymotrypsin

C. Pronase E를 처리한 부분 정제액C. Partial Purified Solution Treated with Pronase E

D. 100℃에서 30분간 처리한 부분 정제액D. Partial Purified Solution Treated at 100 ° C for 30 Minutes

제4도는 부분정제된 박테리오신의 pH 안정성을 나타낸 그림이다.Figure 4 shows the pH stability of partially purified bacteriocins.

제5도는 정제된 박테리오신의 에스디에스 폴리아크릴아마이드 겔 전기영동 사진(A)과 정제된 박테리오신에 의한 락토바실러스 사께의 생육 저 해(B)를 나타낸 사진이다.FIG. 5 is a photograph showing the BD polyacrylamide gel electrophoresis of purified bacteriocin (A) and growth inhibition (B) to Lactobacillus by purified bacteriocin.

1. 저분자량 표준 단백질1. Low Molecular Weight Standard Protein

2. 정제된 박테리오신2. Purified Bacteriocin

[발명의 목적][Purpose of invention]

[발명이 속하는 기술분야 및 그 분야의 종래기술][Technical field to which the invention belongs and the prior art in that field]

본 발명은 식품의 보존 또는 생물제어제로 사용이 가능한 천연 항균물질인 박테리오신(bacteriocin)에 관한 것이다. 박테리오신이란 물질은 데이비스(Davis) 등이 1925년 에스셰리시아 콜라이(Escherichia coli)로부터 미생물의 생장을 억제하는 단백질 물질을 발견하고 이 단백질을 콜리신(colicin)으로 명명한 이후 여러 연구자에 의하여 비슷한 단백질성의 물질이 보고되었다. 이 박테리오신들은 한결같이 항균물질 생산균주 자신과 계통·혈통학적으로 근접한 균종으로 제한된 좁은 항균 범위를 나타내며, 항생물질과 유사한 특징을 가지고 있다.The present invention relates to bacteriocin, a natural antimicrobial material that can be used as a food preservation or biocontrol agent. The bacteriocin is a similar protein by several researchers since Davis et al. Discovered a protein substance that inhibits the growth of microorganisms from Escherichia coli in 1925 and named this protein colicin. Sexual material has been reported. These bacteriocins consistently have a narrow antimicrobial range limited to strains that are closely related to the antimicrobial producing strain itself and to lineage and lineage, and have similar characteristics to antibiotics.

박테리오신 분자는 단백질로 이루어져 있기 때문에 인체에 섭취되는 즉시 소화기관의 단백질 가수분해효소에 의해 분해됨으로써 인체에 무독성이고 잔류성이 없다는 측면에서 식품의 새로운 생물보존제 또는 발효식품의 생물제어제로 그 효용이 크게 기대되고 있다. 지금까지는 식품의 화학적, 미생물학적 또는 효소적 변화에 의한 식품의 변질을 방지하기 위하여 가열, 동결, 건조 등의 물리적 방법과 산성화, 화학합성 보존제, 소금이나 설탕을 이용한 절임 및 훈연 등의 화학적 방법을 사용하여 왔다. 그러나 이러한 방법들은 영양성분의 손실, 텍스춰, 식미의 변화 등 식품의 천연적 품질을 손상시킨다.Because bacteriocin molecules are composed of proteins, they are decomposed by protein hydrolase in the digestive system as soon as they are ingested in the human body. Therefore, they are expected to be useful as new bio-preservatives for foods or biocontrol agents for fermented foods. It is becoming. Until now, physical methods such as heating, freezing and drying and chemical methods such as acidification, chemical synthesis preservatives, pickling and smoking using salt or sugar have been used to prevent food from being deteriorated by chemical, microbiological or enzymatic changes. Has been used. However, these methods impair the natural quality of food, such as loss of nutrients, changes in texture and taste.

젖산균(lactic acid bacteria)은 탄수화물을 혐기적으로 이용하여 젖산을 생산하는 미생물로 자연계에 널리 분포하는 미생물이다. 이 미생물은 중성 및 알칼리성에서 잘 생육하는 부패성 미생물의 생육을 억제하여 동서양을 막론하고 식품의 중요한 보존 수단으로 응용되어 왔으며, 특히 우유, 유제품, 육제품, 침채류 및 각종 젓갈류의 가공에 이용되어 왔다. 젖산균은 이들의 대사산물인 여러 종류의 유기산에 의해 pH를 감소시키면서 식품의 보존성을 증진시키는데, 젖산 및 초산과 같은 유기산은 대부분의 미생물에 대하여 살균작용(bactericidal)이 있기 때문이다. 또한 유기산 이외에 과산화 수소 및 이들이 생산하는 박테리오신이 보존성에 관여한다. 젖산균이 생산하는 가장 널리 알려진 박테리오신인 나이신(nisin)은 광범위한 항균 범위 때문에 오래 전부터 사용이 허용되어 왔으며, 미국에서도 1988년 식품의약안전본부(FDA)가 그라스(GRAS, generally recognized as safe) 식품 첨가물로 인정하게 되었다.Lactic acid bacteria are microorganisms that produce lactic acid by anaerobic carbohydrates and are widely distributed in nature. This microorganism has been applied as an important preservation means of foods in both East and West by suppressing the growth of decaying microorganisms that grow well in neutral and alkaline, especially in the processing of milk, dairy products, meat products, vegetables and various salted fish. come. Lactic acid bacteria improve the preservation of foods by reducing the pH by their various metabolites, organic acids, because organic acids such as lactic acid and acetic acid have bactericidal action against most microorganisms. In addition to organic acids, hydrogen peroxide and the bacteriocins they produce are also involved in conservation. Nisin, the most widely known bacteriocin produced by lactic acid bacteria, has long been allowed for use due to its broad antimicrobial range, and in the United States, the Food and Drug Safety Administration (FDA) in 1988 identified a food additive as Grass (GRAS). Admitted to.

따라서 김치, 장류, 젓갈류 등 전통적으로 자연의 미생물을 이용한 발효식품이 풍부한 우리나라는 이들 식품이 국민 건강을 좌우하는 주요 기초식품을 이루고 있으므로 박테리오신에 대한 과학적, 산업적 응용기술의 개발은 시급하고도 중요하다.Therefore, in Korea, which is rich in fermented foods traditionally made with natural microorganisms such as kimchi, jangjang, and salted fish, these foods constitute the main basic food that affects the health of the people, so the development of scientific and industrial application technologies for bacteriocin is urgent and important. Do.

[발명이 이루고자 하는 기술적 과제][Technical problem to be achieved]

그리하여 본 발명의 목적은 천연 식품보존제로 사용이 가능한 항균범위가 넓은 박테리오신을 생산하는 젖산균을 제공하는 것이다.Therefore, it is an object of the present invention to provide a lactic acid bacterium that produces a bacteriocin having a broad antibacterial range that can be used as a natural food preservative.

[발명의 구성 및 작용][Configuration and Function of Invention]

[발명에 사용된 시료][Sample Used for Invention]

본 발명에 사용된 시료는 시중 대중음식점으로부터 수집한 김치, 시중에서 판매되는 김치 및 가정에서 전통적인 방법으로 제조한 김치를 4℃에 보존하면서 사용하였다.Samples used in the present invention were used while preserving kimchi collected from commercial restaurants, kimchi sold on the market and kimchi prepared by the traditional method at home at 4 ℃.

[젖산균의 분리 및 항균물질 생산균주의 탐색][Isolation of Lactic Acid Bacteria and Screening of Antimicrobial Production Strains]

김치 시료를 멸균 생리적 식염수에 현탁하여 김치 부유물이 침전되도록 5분간 방치한 뒤 생리적 식염수에 순차적으로 희석하여 MRS 한천배지에 도말하고 30℃에서 1-2일간 배양하였다. 형성된 군락은 새로운 MRS 한천배지에 멸균 이쑤시개로 이식하여 30℃에서 군락이 형성될 때까지 배양한 후 지시균으로 김치의 산패 미생물로 알려진 락토바실러스 플란타룸(Locobacillus plantarum)이 함유된 MRS 연한천배지 5ml를 중층하고 lawn이 형성될 때까지 배양하여 군락주위에 저해환의 생성여부를 검토하였다. 저해환이 나타난 균주에 대하여는 박테리오신 생산균주로 1차 선발하였다.Kimchi samples were suspended in sterile physiological saline, allowed to stand for 5 minutes to precipitate the kimchi suspension, and then diluted in physiological saline sequentially and plated on MRS agar medium and incubated at 30 ° C. for 1-2 days. The colonies formed were transplanted into a new MRS agar medium with sterile toothpicks and incubated at 30 ° C. until colonies were formed, and then MRS soft agar medium containing Locobacillus plantarum, known as rancid microorganism of kimchi, was used as an indicator. 5 ml of the layer was incubated until the lawn was formed to examine the formation of inhibitory rings around the colonies. The strain showing the inhibitory ring was first selected as a bacteriocin producing strain.

[실시예 1]Example 1

1차 선발된 균주들은 액체배지에서의 활성 여부를 관찰하여 2차 선발하였다. 1차 선발균주들을 MRS 액체배지에 접종하여 하룻밤 정치배양한 후 원심분리하여 균체는 제거하고 상등액만을 취하여 0.22㎛ 여과막(membrane filter)으로 잔존 균체를 완전히 제거한 후 미리 페트리 접시에 부어 놓은 MRS 한천배지위에 위에 명시한 지시균이 함유되어 있는 MRS 연한천배지 5ml를 중층하여 살균된 tip으로 구멍을 내어 준비한 구멍에 상등액을 100㎕을 넣어 30℃에서 lawn이 형성되도록 배양하여 저해환을 검토한 결과 총 4균주를 선발하였고 그 중에서 저해환이 가장 큰 LAB-A164를 선발하였다.The first selected strains were selected second by observing the activity in the liquid medium. Primary strains were inoculated in MRS liquid medium and incubated overnight, followed by centrifugation to remove the cells, and only the supernatant was removed. The remaining cells were completely removed with a 0.22 μm filter, and then placed on a Petri dish. 5 ml of MRS soft agar medium containing the indicator bacteria specified above was laid and a hole was sterilized with a sterilized tip. 100 μl of supernatant was added to the prepared hole and cultured to form a lawn at 30 ° C. Were selected, and LAB-A164, the largest inhibitory ring, was selected.

[선발된 균주의 동정][Identification of Selected Strains]

선발된 균주인 LAB-A164에 대하여 형태적, 생리적, 생화학적 실험을 통하여 동정을 실시하였다.LAB-A164, a selected strain, was identified through morphological, physiological and biochemical experiments.

[실시예 2]Example 2

LAB-A164에 대한 형태적, 생리적, 생화학적 실험을 한 결과는 표 1과 같았으며, 표 1에서 나타난 결과로 미루어보아 선발된 균주는 유산구균으로 간주되었다.The results of morphological, physiological and biochemical experiments on LAB-A164 were shown in Table 1, and from the results shown in Table 1, the selected strains were considered as lactic acid bacteria.

[실시예 3]Example 3

유산구균으로 간주된 이 선발균주를 기존 종균기관의 대표 균주들과의 전체 세포내 단백질 형식을 에스디에스 폴리아크릴아마이This selection strain, which is considered to be Lactobacillus, is used to express the whole intracellular protein type with representative strains of existing spawn organs.

[표 1]TABLE 1

드 겔 일렉트로포레시스(SDS-polyacrylamide gel electrophoresis)로 비교한 결과 제1도에 나타난 바와 같이 락토코커스 락티스 서브스피시즈 락티스(Lactococcus lactis subsp. lactis) 대표 균주와 일치하는 것으로 보아 선발균주인 LAB-A164를 락토코커스 락티스 서브스피시즈 락티스로 동정하였다.Compared with SDS-polyacrylamide gel electrophoresis, as shown in FIG. 1, it was found to be consistent with the representative strain of Lactococcus lactis subsp. A164 was identified as Lactococcus lactis subsp. Lactis.

[항균활성의 측정]Measurement of Antimicrobial Activity

박테리오신의 항균활성 측정은 spot-on-lawn 방법을 사용하여 수행하였다. 박테리오신 생산균주의 배양액을 10,000 rpm에서 10분간 원심분리하여 상등액을 취하고 잔존 균주를 0.22㎛ 여과막(membrane filter)으로 완전히 제거한 후 앞서 기술한 바와 같이 미리 부어 놓은 고체배지에 점적한 후 상등액이 확산되도록 상온에서 약 30분간 건조시켰다. 항균활성의 정량적인 측정을 위해서는 상등액을 새로운 살균 액체배지를 이용하여 순차적으로 2배씩 희석하여 고체배지에 점적한 후 항균활성을 측정하였고, 활성단위(activity unit, AU)는 1ml 당 항균활성을 나타내는 최대 희석 배수의 역수로 나타내었다.Antimicrobial activity of bacteriocin was measured using the spot-on-lawn method. The supernatant was collected by centrifugation of the bacteriocin producing strain at 10,000 rpm for 10 minutes, and the remaining strain was completely removed with a 0.22 μm membrane, and then dipped into a previously poured solid medium as described above. Dried for about 30 minutes. In order to quantitatively measure the antimicrobial activity, the supernatant was diluted 2 times sequentially using a new sterilizing liquid medium, and then the antimicrobial activity was measured after dropping on a solid medium. The activity unit (AU) showed antimicrobial activity per 1ml. Inverse of the maximum dilution multiples.

[실시예 4]Example 4

[항균범위의 측정][Measurement of Antibacterial Range]

본 발명의 균주인 LAB-A164가 생산하는 박테리오신의 항균범위는 여러 종류의 젖산균과 식품유래 병원성균 및 부패균에 대하여 well-diffusion 방법으로 실시하였다. 본 박테리오신은 락토바실러스(Lactobacillus), 류코노스탁(Leuconostoc), 피디오코커스(Pediococcus) 및 카노박테리움(Carnobacterium) 속을 포함한 모든 젖산균종들에 대하여 광범위한 항균활성을 나타내었으며, 바실러스 쎄레우스(Bacillus cereus), 스타필로코커스 오레우스(Staphylococcus aureus) 및 리스테리아 모노사이토제네스(Listeria monocytogenes)와 같은 식품유래 병원성 미생물에 대하여도 활성을 나타내었다(표 2).The antimicrobial range of the bacteriocin produced by the strain LAB-A164 of the present invention was carried out by a well-diffusion method against various kinds of lactic acid bacteria, food-derived pathogenic bacteria and rot bacteria. The bacteriocin exhibited broad antimicrobial activity against all lactic acid bacteria including Lactobacillus, Leuconostoc, Pediococcus and Carnobacterium genus, and Bacillus cereus cereus), Staphylococcus aureus, and Listeria monocytogenes, such as Listeria monocytogenes was also shown activity against the pathogenic microorganisms (Table 2).

[실시예 5]Example 5

[박테리오신 생산에 대한 최적 생육조건의 확립][Establishment of Optimal Growth Conditions for Bacteriocin Production]

본 발명의 균주인 락토코커스 락티스 서브스피시즈 락티스 A164가 생산하는 박테리오신의 최적 생산조건을 확립하고자 여러 종류의 합성 배지, 배양온도, 배양시간 및 배지의 초기 pH를 각기 달리하In order to establish the optimum conditions for the production of bacteriocin produced by the strain Lactococcus lactis subsp. Lactis A164, various kinds of synthetic media, incubation temperature, incubation time and initial pH of the media were changed.

[표 2]TABLE 2

여 본 균주를 배양하여 균체량과 박테리오신 활성을 측정하였다. 배지로는 M17 배지가 가장 균체증식과 박테리오신 활성이 가장 높게 나타났다. 본 발명 균주를 M17 액체배지에 접종하여, 30℃에서 정치배양한 결과는 제2도와 같았다. 균체증식은 접종한 후 4시간부터 급격히 증가하였고 16시간이 지나면서 부터 정지기에 들어가는 것으로 나타났다. 젖산 생산량은 4-16시간 사이에 가장 높았으며 20시간 후부터는 거의 없었다. 박테리오신 생산은 접종 후 균체생육과 함께 생산되었으며, 배양 16시간만에 최대 생산량을 나타내었으나 20시간이 경과되면서 차츰 감소하는 경향을 나타내었다.By culturing the strain, the cell weight and bacteriocin activity were measured. M17 medium showed the highest cell growth and bacteriocin activity. The strain of the present invention was inoculated in M17 liquid medium, and the result of stationary culture at 30 ° C was the same as that of FIG. Cell growth increased rapidly from 4 hours after inoculation and entered stationary phase after 16 hours. Lactate production was highest between 4-16 hours and rarely after 20 hours. Bacteriocin production was produced with cell growth after inoculation, and showed a maximum yield in 16 hours of culture, but gradually decreased after 20 hours.

[실시예 6]Example 6

[분해효소처리 및 열처리에 대한 영향][Influence on Degrading Enzyme Treatment and Heat Treatment]

본 발명의 균주인 LAB-A164의 부분 정제액을 가지고 본 실험을 수행하였다. LAB-A164의 부분 정제액은 M17 액체배지 100ml에 1%가 되게 접종하여 30℃에서 16시간 배양한 후 8,000rpm에서 10분간 원심분리하여 균체를 제거하여 상등액에 황산암모늄을 35% 포화농도로 첨가한 후 4℃에서 하룻밤 방치하여 12,000rpm에서 20분간 원심분리하여 침전물만을 회수하여 증류수에 현탁한 후 투석을 실시하였다. 투석은 molecular weight cutoff이 3.5 kDa인 투석막을 사용하여 12시간 마다 새로운 증류수로 교환하면서 부분정제하여 -20℃에서 보존하면서 실험에 사용하였다. 이렇게 제조된 박테리오신 부분 정제액에 단백질 가수분해 효소인 trypsin, pepsin, α,β -chymotrypsin, papain, pronase E 및 당분해효소인 α-amylase를 최종농도 1 mg/ml이 되게 첨가하여 37℃에서 2시간 배양하여 반응시킨 후 잔존활력을 측정한 결과 표 3에 나타낸 바와 같이 trypsin, pepesin, papain 및 α-amylase에 의하여는 활성This experiment was carried out with a partial purification of LAB-A164, a strain of the present invention. LAB-A164 partial purified solution was inoculated to 100% M17 liquid medium at 1%, incubated for 16 hours at 30 ° C, centrifuged at 8,000 rpm for 10 minutes to remove cells, and 35% saturated ammonium sulfate was added to the supernatant. After standing at 4 ° C. overnight, centrifugation was carried out at 12,000 rpm for 20 minutes to recover only the precipitate, suspended in distilled water, and then dialyzed. Dialysis was used in the experiment while partially purified with a distilled water every 12 hours using a dialysis membrane having a molecular weight cutoff of 3.5 kDa and stored at -20 ℃. Proteolytic enzymes trypsin, pepsin, α, β -chymotrypsin, papain, pronase E and glycolytic enzyme α-amylase were added to the final concentration of 1 mg / ml to 2, at 37 ° C As a result of measuring the remaining vitality after the reaction by incubation for a time, the activity by trypsin, pepesin, papain and α-amylase as shown in Table 3

[표 3]TABLE 3

에 변화가 없으나 α,β -chymotrypsin에 의하여는 부분적으로 활성이 소실되었고 bacterial protease인 pronase E에 의하여는 활성이 모두 소실되었다. 또한 한천배지 상에서 항균 활성을 비교한 결과 역시 동일한 결과를 보였다(제3도).There was no change in activity, but the activity was partially lost by α, β -chymotrypsin and all activity was lost by pronase E, a bacterial protease. In addition, the results of comparing the antimicrobial activity on the agar medium also showed the same results (Figure 3).

부분정제된 박테리오신 용액을 pH 3.0, 5.0 및 7.0에서 열처리를 하여 잔존활력을 측정한 결과는 표 4와 같다. 100℃에서 30분간 열처리를 하였을 때 pH 3.0에서는 활성의 변화가 없는 반면, pH 5.0과Table 4 shows the results of measuring the remaining vitality by heat treatment of the partially purified bacteriocin solution at pH 3.0, 5.0 and 7.0. When heat-treated at 100 ° C. for 30 minutes, there was no change in activity at pH 3.0, whereas pH 5.0 and

[표 4]TABLE 4

7.0에서는 활성이 부분적으로 소실됨을 알 수 있었다. 121℃에서 15분간 열처리를 하였을 때는 pH 3.0과 5.0에서 활성이 부분적으로 소실되었으며, pH 7.0에서는 활성이 모두 소실되었다. 위 같은 결과로 미루어 볼 때 본 박테리오신은 산성인 조건에서 열에 대하여 안정한 것으로 판단되었다.In 7.0, the activity was partially lost. After heat treatment at 121 ° C. for 15 minutes, activity was partially lost at pH 3.0 and 5.0, and at pH 7.0, all activity was lost. In conclusion, the bacteriocin was found to be stable against heat under acidic conditions.

[실시예 7]Example 7

[박테리오신의 pH에 따른 안정성][Stability of pH of Bacteriocin]

부분 정제 박테리오신액을 pH 2.0에서 10.0까지 완충용액과 1:1로 혼합하여 37℃에서 3시간 방치하여 pH가 고르게 한 후 활성을 측정하였다. 제4도에 나타난 바와 같이 pH 2.0부터 10.0까지 박테리오신 활성을 나타내고 있으나 pH 6.0, 7.0, 8.0에서 가장 높은 활성을 나타내었다. 따라서 본 박테리오신은 산성 pH보다는 중성 pH 부근에서 활성이 가장 높은 것으로 나타났다.Partially purified bacteriocin solution was mixed 1: 1 with a buffer solution from pH 2.0 to 10.0 and left at 37 ° C. for 3 hours to stabilize the pH and then measure the activity. As shown in FIG. 4, bacteriocin activity was shown from pH 2.0 to 10.0, but the highest activity was found at pH 6.0, 7.0, and 8.0. Therefore, this bacteriocin was found to have the highest activity near neutral pH rather than acidic pH.

[실시예 8]Example 8

[박테리오신의 정제][Purification of Bacteriocin]

황산암모늄 침전법으로 단백질 분획을 수집한 부분 정제액 시료 5Oml를 강한 양이온 교환수지인 S-sepharose fast flow 수지 10ml를 1.5×50 cm의 컬럼에 충진시킨 후 50ml의 50 mM 초산나트륨 완충액(pH 5.0)으로 컬럼의 pH를 평형시켰다. 그 후 부분정제액 50ml를 컬럼에 적용하여 50 mM 초산나트륨 완충액(pH 5.0)으로 흡착되지 않은 단백질을 세척한 후 50ml의 0.5 M 염화나트륨이 함유된 50 mM 초산나트륨 완충액으로 용출시켜 단일 peak의 활성 분획을 모으고 이를 막의 분자량이 10 kDa인 ultrafiltration으로 통과시켜 최종 정제 실험을 수행하였다. 제5도에 나타낸 바와 같이 순수한 박테리오신을 얻을 수 있었으며, 직접 에스디에스 폴리아크릴 아마이드 겔 전기영동을 통하여 활성을 측정한 결과 단일 band와 일치함을 알 수 있었다. 분자량은 대략 5.0-5.5 kDa으로 나타났다.50 ml of 50 mM sodium acetate buffer (pH 5.0) was charged with 50 ml of a partially purified liquid sample collected by ammonium sulfate precipitation, 10 ml of a strong cation exchange resin, S-sepharose fast flow resin, in a column of 1.5 × 50 cm. The pH of the column was equilibrated with. Then, 50 ml of partial purification solution was applied to the column to wash unadsorbed protein with 50 mM sodium acetate buffer (pH 5.0), and then eluted with 50 ml of sodium acetate buffer containing 50 ml of 0.5 M sodium chloride. Was collected and passed through ultrafiltration with a molecular weight of 10 kDa to conduct a final purification experiment. As shown in FIG. 5, pure bacteriocin was obtained, and the activity was measured through direct polyacrylamide gel electrophoresis. The molecular weight was found to be approximately 5.0-5.5 kDa.

[실시예 9]Example 9

[박테리오신 생산에 대한 영양원의 효과][Effects of Nutrients on Bacteriocin Production]

본 발명의 균주인 LAB-A164가 생산하는 박테리오신의 최적 생산 배지조성을 확립하고자 다양한 탄소원과 질소원을 달리 첨가하여 본 균주를 배양한 후 균체량과 박테리오신 활성을 측정하였다. 먼저 탄소원으로는 자당(Sucrose), 유당(lactose), 포도당(glucose)이 균체증식에 영향을 미쳤으며, 박테리오신 생산은 유당에서 월등히 높은 것으로 관찰되었다(표 5). 다음 질소원으로는 쏘이톤(soytone), 효모 추출물(yeast extract), 프로티오스 펩톤(Proteose peptone)등이 균체증식에 효과가 있는 것으로 관찰되었고, 박테리오신 생산은 효모 추출물에서 가장 높게 관찰되었다(표 6). 탄소원으로서 유당(lactose)의 최적 박테리오신 생산농도는 0.5 ∼ 1.0 %였으며, 15 ∼ 20 % 에서는 균체량의 증식 및 박테리오신의 생산을 관찰할 수 없었다(표 7). 질소원으로서 효모 추출물의 농도에 따른 박테리오신의 생산량은 15 ∼ 20 %에서 가장 높게 관찰되었으며, 역시 1.0 ∼ 2.0 %의 농도에서는 균체량의 감소와 함께 박테리오신의 생산 저해현상이 관찰되었다(표 8).In order to establish the optimum production medium composition of the bacteriocin produced by the strain of LAB-A164 of the present invention, after culturing the strain by adding various carbon sources and nitrogen sources, the cell weight and bacteriocin activity were measured. First, sucrose (lactose) and glucose (glucose) affected cell growth, and bacteriocin production was significantly higher in lactose (Table 5). As the next nitrogen source, soytone, yeast extract, and proteose peptone were found to be effective in cell growth, and bacteriocin production was highest in yeast extract (Table 6). ). The optimal bacteriocin production concentration of lactose as a carbon source was 0.5-1.0%, and growth of cell mass and production of bacteriocin could not be observed at 15-20% (Table 7). The production of bacteriocin was the highest at 15-20% according to the concentration of yeast extract as a nitrogen source, and the inhibition of bacteriocin production was also observed at the concentration of 1.0-2.0% (Table 8).

[표 5]TABLE 5

[표 6]TABLE 6

[표 7]TABLE 7

[표 8]TABLE 8

Claims (1)

전통발효식품 김치에서 분리되어 락토바실러스, 류코노스탁, 피디오코커스 및 카노박테리움 속을 포함하는 대부분의 젖산균종과 바실러스 쎄레우스, 스타필로코커스 오레우스, 리스테리아 모노사이토제네스와 같은 병원성 미생물에 대하여 폭넓은 항균활성을 가지는 분자량 5.0-5.5 KDa의 순수한 천연항균물질 박테리오신을 생산하는 것을 특징으로하는 락토코커스 락티스 서브스피시즈 락티스 A164(KFCC-11047) 균주.Isolated from traditional fermented food kimchi against most lactic acid species, including Lactobacillus, Leukonostock, Pidiococcus and Canobacterium genus, and pathogenic microorganisms such as Bacillus cereus, Staphylococcus oreus and Listeria monocytogenes Lactococcus lactis subsp. Lactis A164 (KFCC-11047) strain, characterized by producing a pure natural antibacterial bacteriocin having a broad antimicrobial activity of 5.0-5.5 KDa.
KR1019980040669A 1998-09-30 1998-09-30 Lactococcus lactis microorganism producing natural antibacterial substances (KFCC 11047) KR100273742B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019980040669A KR100273742B1 (en) 1998-09-30 1998-09-30 Lactococcus lactis microorganism producing natural antibacterial substances (KFCC 11047)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019980040669A KR100273742B1 (en) 1998-09-30 1998-09-30 Lactococcus lactis microorganism producing natural antibacterial substances (KFCC 11047)

Publications (2)

Publication Number Publication Date
KR20000021520A KR20000021520A (en) 2000-04-25
KR100273742B1 true KR100273742B1 (en) 2001-01-15

Family

ID=19552439

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980040669A KR100273742B1 (en) 1998-09-30 1998-09-30 Lactococcus lactis microorganism producing natural antibacterial substances (KFCC 11047)

Country Status (1)

Country Link
KR (1) KR100273742B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100359289B1 (en) * 2000-06-13 2002-11-07 (주)바이오솔루션 Bacteriocin-coated plastic film and process for preparation thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101676621B1 (en) 2015-01-16 2016-11-16 주식회사 인트론바이오테크놀로지 Novel Lactococcus garvieae bacteriophage Lac-GAP-1 and its use for preventing proliferation of Lactococcus garvieae
KR101723468B1 (en) * 2015-10-23 2017-04-06 주식회사 인트론바이오테크놀로지 Novel Lactococcus garvieae bacteriophage Lac-GAP-2 and its use for preventing proliferation of Lactococcus garvieae
KR102310337B1 (en) 2020-12-04 2021-10-07 주식회사 큐옴바이오 Lactococcus lactis q1 strain having complex digestive productivity and antibacterial activity and uses thereof
CN114395610A (en) * 2022-01-20 2022-04-26 浙江特隆检测技术有限公司 Method for rapidly screening bacteriocin-producing microorganisms

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100359289B1 (en) * 2000-06-13 2002-11-07 (주)바이오솔루션 Bacteriocin-coated plastic film and process for preparation thereof

Also Published As

Publication number Publication date
KR20000021520A (en) 2000-04-25

Similar Documents

Publication Publication Date Title
Ogunbanwo et al. Influence of cultural conditions on the production of bacteriocin by Lactobacillus brevis OG1
Abo-Amer Characterization of a bacteriocin-like inhibitory substance produced by Lactobacillus plantarum isolated from Egyptian home-made yogurt
EA028377B1 (en) Antimicrobial composition
KR101869221B1 (en) A novel Weissella cibaria strain and the use thereof
KR101372200B1 (en) Lactobacillus plantarum SY99 and Use Thereof
Wessels et al. Suitability ofLactococcus lactissubsp. lactisATCC 11454 as a protective culture for lightly preserved fish products
JPWO2005045053A1 (en) Method for producing bacteriocin-containing lactic acid bacteria culture and food preservation method using the same
EP0374823A2 (en) Control of microbial growth with nisin/lysozyme formulations
Daba et al. Detection of bacteriocin-producing lactic acid bacteria from milk in various farms in north-east Algeria by a new procedure.
KR100413335B1 (en) Lactococcus lactis BH5(KCCM-10275) which is produced antimicrobial peptide
Laslo et al. Meat starter cultures: Isolation and characterization of lactic acid bacteria from traditional sausages
US5908646A (en) Inhibition of clostridia with lactic acid bacteria
KR100273742B1 (en) Lactococcus lactis microorganism producing natural antibacterial substances (KFCC 11047)
Prosekov et al. ANTIMICROBIC ACTIVITY OF FRUIT AND VEGETABLES'NATURAL MICROFLORA AS A SOURCE OF RECEIVING BIOPRESERVATIVES
KR0123946B1 (en) Lactococcus sp. which produces novel bacteriocin
Belhadj et al. Isolation, identification and antimicrobial activity of lactic acid bacteria from Algerian honeybee collected pollen
CN104593294B (en) A kind of high bacteriocinogeny enterococcus faecalis and its application
CN115161216A (en) Novel biological preservative and application thereof
Khider et al. Extending the shelf life of Camembert cheese via controlling over-ripening by bacteriocin of newly lactic acid bacterial isolate LAB100
JP2002369678A (en) Method for preventing sundry germs for malted rice
Kim Inhibition of Listeria monocytogenes by bacteriocin (s) from lactic acid bacteria isolated from Kimchi
KR100645089B1 (en) Food Preservatives Comprising Culture broth of Lactic Acid Bacteria and Poly-?-glutamic Acid
JP2002330740A (en) Method for spore bearing bacterium sterilization
Ashiru et al. Isolation of starch degrading spoilage bacteria from'Ogi'(fermenting maize starch)
KR100338393B1 (en) Bacteriocin-producing microorganism isolated from Jeot-gal and process for preparation bacteriocin using the same

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130703

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20140707

Year of fee payment: 15

FPAY Annual fee payment

Payment date: 20150710

Year of fee payment: 16

FPAY Annual fee payment

Payment date: 20170704

Year of fee payment: 18

LAPS Lapse due to unpaid annual fee